How I Diagnose Patients with AML Based on Minimal Residual Disease Testing
Description
Upon viewing this session, you will be able to:
• Describe the advantages and limitations of techniques used for AML MRD assessment
• Recognize the importance of AML MRD for prognostication
• End of Induction
• Pre- and Post-transplant
• Explain the appropriate interpretation of MRD assays dependence on therapy, time point and biologic risk group
• Appreciate the advantages and limitations of high-sensitivity AML MRD assays
• Describe the advantages and limitations of techniques used for AML MRD assessment
• Recognize the importance of AML MRD for prognostication
• End of Induction
• Pre- and Post-transplant
• Explain the appropriate interpretation of MRD assays dependence on therapy, time point and biologic risk group
• Appreciate the advantages and limitations of high-sensitivity AML MRD assays
Presenters
- Brent Wood, MD, PhD, University of Washington
Pricing
| Member Type | Price |
|---|---|
| List Price | $30.00 |
| Active, International, Emeritus, and Honorary Members | $20.00 |
| Associate, International Associate, Student, and Resident Members | $20.00 |
ASH Meeting on Hematologic Malignancies
Hear the latest developments in clinical care, and get answers to your most challenging patient care questions.
Learn more
AMERICAN SOCIETY OF HEMATOLOGY
2021 L Street NW, Suite 900, Washington, DC 20036
Phone 202-776-0544 | Fax 202-776-0545
Copyright © 2021 by American Society of Hematology